- Home
- NXPL vs GRCE Comparison
NXPL vs GRCE Comparison
Compare NXPL & GRCE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- NXPL
- GRCE
- Stock Information
- Founded
- NXPL 1997
- GRCE 2002
- Country
- NXPL United States
- GRCE United States
- Employees
- NXPL N/A
- GRCE N/A
- Industry
- NXPL Telecommunications Equipment
- GRCE
- Sector
- NXPL Telecommunications
- GRCE
- Exchange
- NXPL Nasdaq
- GRCE NYSE
- Market Cap
- NXPL 17.9M
- GRCE 42.1M
- IPO Year
- NXPL N/A
- GRCE N/A
- Fundamental
- Price
- NXPL $0.77
- GRCE $3.13
- Analyst Decision
- NXPL
- GRCE Strong Buy
- Analyst Count
- NXPL 0
- GRCE 1
- Target Price
- NXPL N/A
- GRCE $12.00
- AVG Volume (30 Days)
- NXPL 32.6K
- GRCE 55.8K
- Earning Date
- NXPL 08-13-2025
- GRCE 06-23-2025
- Dividend Yield
- NXPL N/A
- GRCE N/A
- EPS Growth
- NXPL N/A
- GRCE N/A
- EPS
- NXPL N/A
- GRCE N/A
- Revenue
- NXPL $62,515,000.00
- GRCE N/A
- Revenue This Year
- NXPL N/A
- GRCE N/A
- Revenue Next Year
- NXPL N/A
- GRCE N/A
- P/E Ratio
- NXPL N/A
- GRCE N/A
- Revenue Growth
- NXPL 19.36
- GRCE N/A
- 52 Week Low
- NXPL $0.43
- GRCE $1.75
- 52 Week High
- NXPL $2.30
- GRCE $4.97
- Technical
- Relative Strength Index (RSI)
- NXPL 62.83
- GRCE N/A
- Support Level
- NXPL $0.68
- GRCE N/A
- Resistance Level
- NXPL $0.85
- GRCE N/A
- Average True Range (ATR)
- NXPL 0.07
- GRCE 0.00
- MACD
- NXPL 0.00
- GRCE 0.00
- Stochastic Oscillator
- NXPL 61.74
- GRCE 0.00
About NXPL NextPlat Corp
NextPlat Corp is an e-commerce and healthcare company. Its e-commerce venues form an effective network serving thousands of consumers, enterprises, and governments. Its healthcare business is focused on improving the lives of patients with complex chronic diseases through patient and provider engagement and their partnerships with payors, pharmaceutical manufacturers, and distributors, offering a broad range of solutions to address the dispensing, delivery, dosing, and reimbursement of clinically intensive, high-cost drugs. The company operates in two segments: e-Commerce Operations involves acquiring and leasing an e-commerce platform; and Healthcare Operations provides TPA, data management, COVID-19 related diagnostics and vaccinations, prescription pharmaceuticals, and Others.
About GRCE GRACE THERAPEUTICS INC
Grace Therapeutics Inc is a late-stage specialty pharma company with drug delivery technologies and drug candidates addressing rare and orphan diseases. The company's lead drug candidate, GTx-104, is a novel injectable formulation of nimodipine for the treatment of a rare disease, aneurysmal subarachnoid hemorrhage.